Pharma evidence system gets a digital upgrade

A Sonata whitepaper argues that AI, interoperability standards, blockchain, and connected devices enable a shift from episodic randomized controlled trials to a continuous, integrated evidence ecosystem called Evidence 2.0. The framework aims to make drug evidence transparent, patient-centered, and dynamically updated throughout a medicine's lifecycle.